Usage: Duloxetine delayed-release capsules are indicated for the treatment of major depressive disorder, generalized anxiety disorder (in adults and children 7+), diabetic peripheral neuropathic pain, fibromyalgia (in patients 13+), and chronic musculoskeletal pain in adults.
Usage: Duloxetine delayed-release capsules are indicated for treating major depressive disorder, generalized anxiety disorder (in adults and pediatric patients 7+), diabetic peripheral neuropathic pain, fibromyalgia (in patients 13+), and chronic musculoskeletal pain in adults.
Usage: Duloxetine delayed-release capsules are indicated for the treatment of Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, and Chronic Musculoskeletal Pain.
Usage: Effexor XR is indicated for the treatment of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), and Panic Disorder (PD) in adults.
Usage: Duloxetine delayed-release capsules are indicated for treating Major Depressive Disorder, Generalized Anxiety Disorder (in adults and pediatric patients 7+), Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain in adults.
Usage: Venlafaxine extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and social anxiety disorder (SAD). Efficacy for both conditions was demonstrated in clinical trials. MDD involves persistent depressed mood or loss of interest, while SAD is characterized by intense fear in social situations, affecting daily functioning.